

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 8.50077163 |
| 2 | actin-myosin filament sliding (GO:0033275) | 8.50077163 |
| 3 | regulation of skeletal muscle contraction (GO:0014819) | 8.27220166 |
| 4 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 8.21124882 |
| 5 | skeletal muscle contraction (GO:0003009) | 7.41521941 |
| 6 | actin-mediated cell contraction (GO:0070252) | 6.97012957 |
| 7 | skeletal muscle adaptation (GO:0043501) | 6.28087973 |
| 8 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.10582140 |
| 9 | skeletal muscle fiber development (GO:0048741) | 5.54376677 |
| 10 | plasma membrane repair (GO:0001778) | 5.28408931 |
| 11 | neuronal action potential propagation (GO:0019227) | 5.24430901 |
| 12 | actin filament-based movement (GO:0030048) | 5.23276374 |
| 13 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.16815119 |
| 14 | creatine metabolic process (GO:0006600) | 5.15090675 |
| 15 | sarcomere organization (GO:0045214) | 5.05521550 |
| 16 | striated muscle contraction (GO:0006941) | 5.03740392 |
| 17 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.98884257 |
| 18 | regulation of cell communication by electrical coupling (GO:0010649) | 4.86806334 |
| 19 | * regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.85480615 |
| 20 | myotube cell development (GO:0014904) | 4.78396746 |
| 21 | myofibril assembly (GO:0030239) | 4.70323072 |
| 22 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.61006821 |
| 23 | NADH metabolic process (GO:0006734) | 4.43896906 |
| 24 | response to inactivity (GO:0014854) | 4.33232057 |
| 25 | negative regulation of protein localization to cell surface (GO:2000009) | 4.29844564 |
| 26 | IMP metabolic process (GO:0046040) | 4.28147907 |
| 27 | cardiac muscle hypertrophy (GO:0003300) | 4.28107946 |
| 28 | glycogen catabolic process (GO:0005980) | 4.18434674 |
| 29 | muscle contraction (GO:0006936) | 4.10331742 |
| 30 | striated muscle hypertrophy (GO:0014897) | 4.06973303 |
| 31 | striated muscle atrophy (GO:0014891) | 4.00643755 |
| 32 | glucan catabolic process (GO:0009251) | 3.88584534 |
| 33 | carnitine shuttle (GO:0006853) | 3.87707830 |
| 34 | response to muscle activity (GO:0014850) | 3.84038352 |
| 35 | tricarboxylic acid cycle (GO:0006099) | 3.83451504 |
| 36 | adult heart development (GO:0007512) | 3.79020129 |
| 37 | muscle cell fate commitment (GO:0042693) | 3.77867623 |
| 38 | cardiac muscle cell development (GO:0055013) | 3.75680591 |
| 39 | striated muscle adaptation (GO:0014888) | 3.71922461 |
| 40 | actomyosin structure organization (GO:0031032) | 3.70953066 |
| 41 | muscle atrophy (GO:0014889) | 3.66704476 |
| 42 | muscle system process (GO:0003012) | 3.65418840 |
| 43 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.63326990 |
| 44 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.61096480 |
| 45 | muscle tissue morphogenesis (GO:0060415) | 3.60512778 |
| 46 | neuromuscular synaptic transmission (GO:0007274) | 3.60440062 |
| 47 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.60345514 |
| 48 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.59528635 |
| 49 | muscle fiber development (GO:0048747) | 3.56699414 |
| 50 | 2-oxoglutarate metabolic process (GO:0006103) | 3.56431089 |
| 51 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.55122856 |
| 52 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.55111215 |
| 53 | muscle organ morphogenesis (GO:0048644) | 3.54959357 |
| 54 | cellular polysaccharide catabolic process (GO:0044247) | 3.54370211 |
| 55 | muscle hypertrophy (GO:0014896) | 3.52503274 |
| 56 | fructose metabolic process (GO:0006000) | 3.51438081 |
| 57 | cardiac muscle contraction (GO:0060048) | 3.47315020 |
| 58 | gluconeogenesis (GO:0006094) | 3.45924256 |
| 59 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.45355366 |
| 60 | * regulation of calcium ion transmembrane transport (GO:1903169) | 3.43665773 |
| 61 | * regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.43665773 |
| 62 | cardiac cell development (GO:0055006) | 3.42921249 |
| 63 | regulation of actin filament-based movement (GO:1903115) | 3.39614343 |
| 64 | axon ensheathment in central nervous system (GO:0032291) | 3.38813437 |
| 65 | central nervous system myelination (GO:0022010) | 3.38813437 |
| 66 | polysaccharide catabolic process (GO:0000272) | 3.36618170 |
| 67 | response to activity (GO:0014823) | 3.31363262 |
| 68 | muscle cell cellular homeostasis (GO:0046716) | 3.31340468 |
| 69 | regulation of striated muscle contraction (GO:0006942) | 3.30833219 |
| 70 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.30813762 |
| 71 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.30813762 |
| 72 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.30329184 |
| 73 | muscle cell development (GO:0055001) | 3.26933775 |
| 74 | cardiac myofibril assembly (GO:0055003) | 3.21760656 |
| 75 | positive regulation of myotube differentiation (GO:0010831) | 3.21653583 |
| 76 | regulation of relaxation of muscle (GO:1901077) | 3.21439546 |
| 77 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.21366658 |
| 78 | regulation of membrane repolarization (GO:0060306) | 3.21216001 |
| 79 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.20525283 |
| 80 | muscle hypertrophy in response to stress (GO:0003299) | 3.20525283 |
| 81 | cardiac muscle adaptation (GO:0014887) | 3.20525283 |
| 82 | skeletal muscle tissue regeneration (GO:0043403) | 3.19580558 |
| 83 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.19215634 |
| 84 | neuromuscular junction development (GO:0007528) | 3.18598632 |
| 85 | regulation of cofactor metabolic process (GO:0051193) | 3.13745235 |
| 86 | regulation of coenzyme metabolic process (GO:0051196) | 3.13745235 |
| 87 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.10512964 |
| 88 | membrane depolarization during action potential (GO:0086010) | 3.10194896 |
| 89 | hexose biosynthetic process (GO:0019319) | 3.09802165 |
| 90 | fatty acid transmembrane transport (GO:1902001) | 3.09309312 |
| 91 | IMP biosynthetic process (GO:0006188) | 3.06797531 |
| 92 | striated muscle tissue development (GO:0014706) | 3.03387375 |
| 93 | cellular carbohydrate catabolic process (GO:0044275) | 3.03329397 |
| 94 | relaxation of muscle (GO:0090075) | 3.02018648 |
| 95 | potassium ion import (GO:0010107) | 3.00706465 |
| 96 | aspartate family amino acid catabolic process (GO:0009068) | 3.00539443 |
| 97 | glycogen biosynthetic process (GO:0005978) | 3.00041472 |
| 98 | glucan biosynthetic process (GO:0009250) | 3.00041472 |
| 99 | positive regulation of cation channel activity (GO:2001259) | 2.96881107 |
| 100 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.96307854 |
| 101 | regulation of the force of heart contraction (GO:0002026) | 2.95463763 |
| 102 | * muscle structure development (GO:0061061) | 2.94789453 |
| 103 | * muscle organ development (GO:0007517) | 2.94775079 |
| 104 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.94713101 |
| 105 | AMP metabolic process (GO:0046033) | 2.94603047 |
| 106 | muscle adaptation (GO:0043500) | 2.94422013 |
| 107 | myotube differentiation (GO:0014902) | 2.92898531 |
| 108 | myoblast fusion (GO:0007520) | 2.90633354 |
| 109 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.90304853 |
| 110 | membrane tubulation (GO:0097320) | 2.89479396 |
| 111 | glutamate receptor signaling pathway (GO:0007215) | 2.86110847 |
| 112 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.82174379 |
| 113 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.69997187 |
| 114 | carnitine transmembrane transport (GO:1902603) | 2.69538818 |
| 115 | calcium ion import (GO:0070509) | 2.68968975 |
| 116 | striated muscle cell development (GO:0055002) | 2.68651126 |
| 117 | cellular response to electrical stimulus (GO:0071257) | 2.67321910 |
| 118 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.67142011 |
| 119 | cellular potassium ion homeostasis (GO:0030007) | 2.66470981 |
| 120 | * regulation of cation channel activity (GO:2001257) | 2.65260527 |
| 121 | negative regulation of muscle hypertrophy (GO:0014741) | 2.63953191 |
| 122 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.61050388 |
| 123 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.60756029 |
| 124 | glycogen metabolic process (GO:0005977) | 2.60115585 |
| 125 | neuron recognition (GO:0008038) | 2.59681575 |
| 126 | axonal fasciculation (GO:0007413) | 2.57227811 |
| 127 | skeletal muscle tissue development (GO:0007519) | 2.55875520 |
| 128 | positive regulation of potassium ion transport (GO:0043268) | 2.55379691 |
| 129 | establishment of mitochondrion localization (GO:0051654) | 2.54033165 |
| 130 | cellular glucan metabolic process (GO:0006073) | 2.53881062 |
| 131 | glucan metabolic process (GO:0044042) | 2.53881062 |
| 132 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.51992375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.97005723 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.02308351 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.81731855 |
| 4 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.55477354 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.49406748 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.49085891 |
| 7 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.49004185 |
| 8 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.47360655 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.37782044 |
| 10 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.35436720 |
| 11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.33005187 |
| 12 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.29791150 |
| 13 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.26434805 |
| 14 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.26434805 |
| 15 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.22453535 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.20281921 |
| 17 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.19377737 |
| 18 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.14704352 |
| 19 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.06342971 |
| 20 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.06315933 |
| 21 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.05112999 |
| 22 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.03378908 |
| 23 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.02411080 |
| 24 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.99254505 |
| 25 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.98367799 |
| 26 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.96634672 |
| 27 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.93758620 |
| 28 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.89561406 |
| 29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.88538150 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.84073022 |
| 31 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.80893969 |
| 32 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.76334376 |
| 33 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.75162185 |
| 34 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.74768552 |
| 35 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.74709370 |
| 36 | VDR_22108803_ChIP-Seq_LS180_Human | 1.70620031 |
| 37 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.67252545 |
| 38 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.66725173 |
| 39 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.65355670 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.64185125 |
| 41 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.61542592 |
| 42 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.48281956 |
| 43 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.39771445 |
| 44 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.39452326 |
| 45 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.38490821 |
| 46 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.37747863 |
| 47 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.35657092 |
| 48 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.33529222 |
| 49 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.30717820 |
| 50 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.30427451 |
| 51 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.29946972 |
| 52 | FUS_26573619_Chip-Seq_HEK293_Human | 1.29261978 |
| 53 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.27436456 |
| 54 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.27408655 |
| 55 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27035498 |
| 56 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.25008871 |
| 57 | TP53_16413492_ChIP-PET_HCT116_Human | 1.24827139 |
| 58 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24495091 |
| 59 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.24410152 |
| 60 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.24311300 |
| 61 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.23859257 |
| 62 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.22710434 |
| 63 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.22710434 |
| 64 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22457511 |
| 65 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.22036127 |
| 66 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.21660366 |
| 67 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.21643706 |
| 68 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.20872551 |
| 69 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.20664915 |
| 70 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.20594905 |
| 71 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.18628049 |
| 72 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.17487902 |
| 73 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.16765482 |
| 74 | AR_25329375_ChIP-Seq_VCAP_Human | 1.15187154 |
| 75 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.15047564 |
| 76 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.14501443 |
| 77 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.14076062 |
| 78 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13500790 |
| 79 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.13105701 |
| 80 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.12239387 |
| 81 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.11962323 |
| 82 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.11749132 |
| 83 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11493669 |
| 84 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.11428291 |
| 85 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.11229171 |
| 86 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.10374484 |
| 87 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.09791352 |
| 88 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.09314827 |
| 89 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08496993 |
| 90 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.08426942 |
| 91 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.08248812 |
| 92 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08097752 |
| 93 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.07994486 |
| 94 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.07994486 |
| 95 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.07834346 |
| 96 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07379908 |
| 97 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06946467 |
| 98 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.06428243 |
| 99 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.05892206 |
| 100 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.05182269 |
| 101 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04301224 |
| 102 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.04190626 |
| 103 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03878890 |
| 104 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03297052 |
| 105 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.02913554 |
| 106 | P300_19829295_ChIP-Seq_ESCs_Human | 1.02600447 |
| 107 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.02060776 |
| 108 | AR_19668381_ChIP-Seq_PC3_Human | 1.00163030 |
| 109 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.99867436 |
| 110 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.99424115 |
| 111 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.99051824 |
| 112 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.98217206 |
| 113 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98082598 |
| 114 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97524123 |
| 115 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.97367654 |
| 116 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97033560 |
| 117 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.97011972 |
| 118 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.96973188 |
| 119 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.96678168 |
| 120 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96124642 |
| 121 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96090245 |
| 122 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.95519834 |
| 123 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.94758966 |
| 124 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.94727016 |
| 125 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.94593735 |
| 126 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.93465357 |
| 127 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.92768456 |
| 128 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.92295990 |
| 129 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.90814655 |
| 130 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90628053 |
| 131 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.90603616 |
| 132 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.89436577 |
| 133 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89353410 |
| 134 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89307811 |
| 135 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.89157261 |
| 136 | NFYB_21822215_ChIP-Seq_K562_Human | 0.88967266 |
| 137 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.87928757 |
| 138 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87638861 |
| 139 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.86904262 |
| 140 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.86904262 |
| 141 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.86744403 |
| 142 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.86158889 |
| 143 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.86158889 |
| 144 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.85288008 |
| 145 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.85074451 |
| 146 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.84833237 |
| 147 | TBL1_22424771_ChIP-Seq_293T_Human | 0.84637660 |
| 148 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.84129928 |
| 149 | RXR_22108803_ChIP-Seq_LS180_Human | 0.83744171 |
| 150 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.83061379 |
| 151 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.82206544 |
| 152 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.81882884 |
| 153 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.81370499 |
| 154 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.81276741 |
| 155 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.80712295 |
| 156 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.78263609 |
| 157 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.78133610 |
| 158 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.77488209 |
| 159 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.77281391 |
| 160 | CBP_21632823_ChIP-Seq_H3396_Human | 0.76988564 |
| 161 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.76638729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 6.76493027 |
| 2 | MP0000749_muscle_degeneration | 5.14635199 |
| 3 | MP0000751_myopathy | 4.89412954 |
| 4 | MP0003646_muscle_fatigue | 4.76091023 |
| 5 | MP0000747_muscle_weakness | 3.62588423 |
| 6 | MP0004036_abnormal_muscle_relaxation | 3.54383933 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 3.48301985 |
| 8 | MP0002106_abnormal_muscle_physiology | 3.42677821 |
| 9 | MP0004859_abnormal_synaptic_plasticity | 3.17532345 |
| 10 | MP0004270_analgesia | 3.07591627 |
| 11 | * MP0000759_abnormal_skeletal_muscle | 2.96072313 |
| 12 | MP0005369_muscle_phenotype | 2.91294767 |
| 13 | MP0002269_muscular_atrophy | 2.81769765 |
| 14 | * MP0004087_abnormal_muscle_fiber | 2.76488804 |
| 15 | MP0005451_abnormal_body_composition | 2.69456226 |
| 16 | * MP0005620_abnormal_muscle_contractility | 2.66971847 |
| 17 | MP0000750_abnormal_muscle_regeneration | 2.43606136 |
| 18 | MP0004130_abnormal_muscle_cell | 2.40603200 |
| 19 | MP0004233_abnormal_muscle_weight | 2.20887489 |
| 20 | MP0003880_abnormal_central_pattern | 2.01392663 |
| 21 | MP0005330_cardiomyopathy | 1.96405738 |
| 22 | MP0004215_abnormal_myocardial_fiber | 1.96344399 |
| 23 | MP0000733_abnormal_muscle_development | 1.80686320 |
| 24 | MP0004484_altered_response_of | 1.73801799 |
| 25 | MP0002108_abnormal_muscle_morphology | 1.72580165 |
| 26 | MP0002332_abnormal_exercise_endurance | 1.71649559 |
| 27 | MP0004084_abnormal_cardiac_muscle | 1.70628872 |
| 28 | MP0003635_abnormal_synaptic_transmissio | 1.70113904 |
| 29 | MP0003950_abnormal_plasma_membrane | 1.69838543 |
| 30 | MP0002972_abnormal_cardiac_muscle | 1.41972885 |
| 31 | MP0009745_abnormal_behavioral_response | 1.41114333 |
| 32 | MP0002272_abnormal_nervous_system | 1.35853828 |
| 33 | MP0002063_abnormal_learning/memory/cond | 1.35609082 |
| 34 | MP0003137_abnormal_impulse_conducting | 1.33287437 |
| 35 | MP0008569_lethality_at_weaning | 1.26931064 |
| 36 | MP0004185_abnormal_adipocyte_glucose | 1.24711525 |
| 37 | MP0002127_abnormal_cardiovascular_syste | 1.24458885 |
| 38 | MP0002734_abnormal_mechanical_nocicepti | 1.24200143 |
| 39 | MP0001661_extended_life_span | 1.24014022 |
| 40 | MP0002064_seizures | 1.22336675 |
| 41 | MP0001440_abnormal_grooming_behavior | 1.17489117 |
| 42 | MP0006036_abnormal_mitochondrial_physio | 1.16534672 |
| 43 | MP0003329_amyloid_beta_deposits | 1.12819083 |
| 44 | MP0001486_abnormal_startle_reflex | 1.12138273 |
| 45 | MP0000920_abnormal_myelination | 1.11489511 |
| 46 | MP0009046_muscle_twitch | 1.07964465 |
| 47 | MP0004510_myositis | 1.04816149 |
| 48 | MP0003123_paternal_imprinting | 1.03698867 |
| 49 | MP0002735_abnormal_chemical_nociception | 1.01475961 |
| 50 | MP0003941_abnormal_skin_development | 1.00922878 |
| 51 | MP0002572_abnormal_emotion/affect_behav | 1.00298413 |
| 52 | MP0010630_abnormal_cardiac_muscle | 0.99811808 |
| 53 | MP0002234_abnormal_pharynx_morphology | 0.99623806 |
| 54 | MP0004142_abnormal_muscle_tone | 0.98911993 |
| 55 | MP0001299_abnormal_eye_distance/ | 0.98616786 |
| 56 | MP0004043_abnormal_pH_regulation | 0.96799587 |
| 57 | MP0004134_abnormal_chest_morphology | 0.95112820 |
| 58 | MP0002971_abnormal_brown_adipose | 0.94922074 |
| 59 | MP0009697_abnormal_copulation | 0.94096047 |
| 60 | MP0009672_abnormal_birth_weight | 0.93412491 |
| 61 | MP0002067_abnormal_sensory_capabilities | 0.93241100 |
| 62 | MP0001346_abnormal_lacrimal_gland | 0.92823596 |
| 63 | MP0005666_abnormal_adipose_tissue | 0.88935459 |
| 64 | MP0002066_abnormal_motor_capabilities/c | 0.86219480 |
| 65 | MP0000013_abnormal_adipose_tissue | 0.85437513 |
| 66 | MP0001501_abnormal_sleep_pattern | 0.85216450 |
| 67 | MP0004085_abnormal_heartbeat | 0.83925006 |
| 68 | MP0002822_catalepsy | 0.83224988 |
| 69 | MP0002254_reproductive_system_inflammat | 0.82187325 |
| 70 | MP0005375_adipose_tissue_phenotype | 0.81148302 |
| 71 | MP0001544_abnormal_cardiovascular_syste | 0.79996907 |
| 72 | MP0005385_cardiovascular_system_phenoty | 0.79996907 |
| 73 | MP0010030_abnormal_orbit_morphology | 0.77825806 |
| 74 | MP0009780_abnormal_chondrocyte_physiolo | 0.77538593 |
| 75 | MP0003221_abnormal_cardiomyocyte_apopto | 0.71338088 |
| 76 | MP0000955_abnormal_spinal_cord | 0.70593921 |
| 77 | MP0000778_abnormal_nervous_system | 0.69471570 |
| 78 | MP0001968_abnormal_touch/_nociception | 0.69392385 |
| 79 | MP0001348_abnormal_lacrimal_gland | 0.67971303 |
| 80 | MP0000762_abnormal_tongue_morphology | 0.67854983 |
| 81 | MP0006138_congestive_heart_failure | 0.67796049 |
| 82 | MP0003633_abnormal_nervous_system | 0.67276053 |
| 83 | MP0008057_abnormal_DNA_replication | 0.66353984 |
| 84 | MP0000266_abnormal_heart_morphology | 0.65700799 |
| 85 | MP0001529_abnormal_vocalization | 0.65671521 |
| 86 | MP0009250_abnormal_appendicular_skeleto | 0.65608519 |
| 87 | MP0002184_abnormal_innervation | 0.65294048 |
| 88 | MP0005623_abnormal_meninges_morphology | 0.65136908 |
| 89 | MP0005266_abnormal_metabolism | 0.65024621 |
| 90 | MP0000003_abnormal_adipose_tissue | 0.64758718 |
| 91 | MP0004858_abnormal_nervous_system | 0.64370667 |
| 92 | MP0008775_abnormal_heart_ventricle | 0.64207805 |
| 93 | MP0003879_abnormal_hair_cell | 0.63515542 |
| 94 | MP0004924_abnormal_behavior | 0.63065859 |
| 95 | MP0005386_behavior/neurological_phenoty | 0.63065859 |
| 96 | MP0002882_abnormal_neuron_morphology | 0.62480711 |
| 97 | MP0004147_increased_porphyrin_level | 0.61872087 |
| 98 | MP0010678_abnormal_skin_adnexa | 0.61486868 |
| 99 | MP0000579_abnormal_nail_morphology | 0.60901038 |
| 100 | MP0004885_abnormal_endolymph | 0.60713019 |
| 101 | MP0001485_abnormal_pinna_reflex | 0.60353799 |
| 102 | MP0002736_abnormal_nociception_after | 0.60061142 |
| 103 | MP0000383_abnormal_hair_follicle | 0.58931185 |
| 104 | MP0003631_nervous_system_phenotype | 0.58597886 |
| 105 | MP0005423_abnormal_somatic_nervous | 0.58162050 |
| 106 | MP0001970_abnormal_pain_threshold | 0.57702768 |
| 107 | MP0000372_irregular_coat_pigmentation | 0.55827044 |
| 108 | MP0006035_abnormal_mitochondrial_morpho | 0.54892695 |
| 109 | MP0005645_abnormal_hypothalamus_physiol | 0.53156741 |
| 110 | MP0003045_fibrosis | 0.52755836 |
| 111 | MP0002114_abnormal_axial_skeleton | 0.51259779 |
| 112 | MP0002078_abnormal_glucose_homeostasis | 0.51225044 |
| 113 | MP0005187_abnormal_penis_morphology | 0.50315062 |
| 114 | MP0001905_abnormal_dopamine_level | 0.50269361 |
| 115 | MP0004811_abnormal_neuron_physiology | 0.50204516 |
| 116 | MP0004197_abnormal_fetal_growth/weight/ | 0.48768394 |
| 117 | MP0002638_abnormal_pupillary_reflex | 0.48319921 |
| 118 | MP0009703_decreased_birth_body | 0.47874005 |
| 119 | MP0010234_abnormal_vibrissa_follicle | 0.45689205 |
| 120 | MP0005670_abnormal_white_adipose | 0.45487707 |
| 121 | MP0005452_abnormal_adipose_tissue | 0.41951833 |
| 122 | MP0001984_abnormal_olfaction | 0.40221294 |
| 123 | MP0002128_abnormal_blood_circulation | 0.30370107 |
| 124 | MP0002249_abnormal_larynx_morphology | 0.29326400 |
| 125 | MP0003567_abnormal_fetal_cardiomyocyte | 0.29080595 |
| 126 | MP0001943_abnormal_respiration | 0.28555372 |
| 127 | MP0005332_abnormal_amino_acid | 0.25962148 |
| 128 | MP0003890_abnormal_embryonic-extraembry | 0.23953792 |
| 129 | MP0010094_abnormal_chromosome_stability | 0.23810140 |
| 130 | MP0001730_embryonic_growth_arrest | 0.23271728 |
| 131 | * MP0002081_perinatal_lethality | 0.22398156 |
| 132 | MP0002896_abnormal_bone_mineralization | 0.22211265 |
| 133 | MP0005083_abnormal_biliary_tract | 0.21634002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 8.52740171 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.27692300 |
| 3 | Exercise-induced myalgia (HP:0003738) | 7.75321636 |
| 4 | Nemaline bodies (HP:0003798) | 7.74579668 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 7.12351536 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 6.89689476 |
| 7 | Type 1 muscle fiber predominance (HP:0003803) | 6.30807536 |
| 8 | Calf muscle hypertrophy (HP:0008981) | 6.24899247 |
| 9 | Distal arthrogryposis (HP:0005684) | 6.23296334 |
| 10 | Myopathic facies (HP:0002058) | 5.43117474 |
| 11 | Round ear (HP:0100830) | 5.41884751 |
| 12 | Difficulty running (HP:0009046) | 5.29712956 |
| 13 | Muscle fiber splitting (HP:0003555) | 5.28757014 |
| 14 | Hyporeflexia of lower limbs (HP:0002600) | 4.63679277 |
| 15 | Ulnar deviation of the wrist (HP:0003049) | 4.63097207 |
| 16 | EMG: myopathic abnormalities (HP:0003458) | 4.50218885 |
| 17 | Abnormality of the calf musculature (HP:0001430) | 4.44370147 |
| 18 | Myoglobinuria (HP:0002913) | 4.30948241 |
| 19 | Calcaneovalgus deformity (HP:0001848) | 4.24807641 |
| 20 | Muscle stiffness (HP:0003552) | 4.14457987 |
| 21 | Myotonia (HP:0002486) | 4.10149813 |
| 22 | Absent phalangeal crease (HP:0006109) | 4.03569438 |
| 23 | Deformed tarsal bones (HP:0008119) | 3.86914773 |
| 24 | Increased connective tissue (HP:0009025) | 3.55607372 |
| 25 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.44133122 |
| 26 | Sudden death (HP:0001699) | 3.43506147 |
| 27 | Abnormal finger flexion creases (HP:0006143) | 3.42228022 |
| 28 | Neck muscle weakness (HP:0000467) | 3.38981277 |
| 29 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.33879444 |
| 30 | Subaortic stenosis (HP:0001682) | 3.33879444 |
| 31 | Rhabdomyolysis (HP:0003201) | 3.27687037 |
| 32 | Increased variability in muscle fiber diameter (HP:0003557) | 3.24785528 |
| 33 | Difficulty climbing stairs (HP:0003551) | 3.19284208 |
| 34 | Malignant hyperthermia (HP:0002047) | 3.18578620 |
| 35 | Hyperkalemia (HP:0002153) | 2.97078316 |
| 36 | Rimmed vacuoles (HP:0003805) | 2.90310298 |
| 37 | Focal motor seizures (HP:0011153) | 2.84129604 |
| 38 | Shoulder girdle muscle weakness (HP:0003547) | 2.75734326 |
| 39 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.64901234 |
| 40 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.64901234 |
| 41 | Pelvic girdle muscle weakness (HP:0003749) | 2.57088983 |
| 42 | Areflexia of lower limbs (HP:0002522) | 2.50288970 |
| 43 | Progressive muscle weakness (HP:0003323) | 2.49543154 |
| 44 | Frequent falls (HP:0002359) | 2.47261145 |
| 45 | Slender build (HP:0001533) | 2.47030803 |
| 46 | Fetal akinesia sequence (HP:0001989) | 2.42847457 |
| 47 | Abnormality of the neuromuscular junction (HP:0003398) | 2.42631237 |
| 48 | Fatigable weakness (HP:0003473) | 2.42631237 |
| 49 | Gowers sign (HP:0003391) | 2.39465230 |
| 50 | Nonprogressive disorder (HP:0003680) | 2.38600764 |
| 51 | Muscular dystrophy (HP:0003560) | 2.36348358 |
| 52 | Hypoplastic ischia (HP:0003175) | 2.34331954 |
| 53 | Abnormality of the calcaneus (HP:0008364) | 2.33559697 |
| 54 | Asymmetric septal hypertrophy (HP:0001670) | 2.33248838 |
| 55 | EMG: neuropathic changes (HP:0003445) | 2.32393908 |
| 56 | Distal lower limb amyotrophy (HP:0008944) | 2.29203207 |
| 57 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.18232810 |
| 58 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.18081706 |
| 59 | Paralysis (HP:0003470) | 2.15938916 |
| 60 | Generalized muscle weakness (HP:0003324) | 2.14871871 |
| 61 | Popliteal pterygium (HP:0009756) | 2.13093774 |
| 62 | Bulbar palsy (HP:0001283) | 2.10910931 |
| 63 | Proximal amyotrophy (HP:0007126) | 2.10708071 |
| 64 | Scapular winging (HP:0003691) | 2.10568152 |
| 65 | Limb-girdle muscle weakness (HP:0003325) | 2.09808613 |
| 66 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.06975994 |
| 67 | Broad-based gait (HP:0002136) | 2.06581836 |
| 68 | Weak cry (HP:0001612) | 2.06268939 |
| 69 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.06007281 |
| 70 | Abnormality of the ischium (HP:0003174) | 2.03391951 |
| 71 | Long clavicles (HP:0000890) | 1.98933944 |
| 72 | Distal lower limb muscle weakness (HP:0009053) | 1.98011671 |
| 73 | Ventricular tachycardia (HP:0004756) | 1.97416124 |
| 74 | Lower limb amyotrophy (HP:0007210) | 1.95494380 |
| 75 | Heart block (HP:0012722) | 1.94770998 |
| 76 | Ulnar deviation of finger (HP:0009465) | 1.91889191 |
| 77 | Achilles tendon contracture (HP:0001771) | 1.89443354 |
| 78 | Spinal rigidity (HP:0003306) | 1.84592462 |
| 79 | Hip contracture (HP:0003273) | 1.83696494 |
| 80 | Limb-girdle muscle atrophy (HP:0003797) | 1.82358652 |
| 81 | Exercise intolerance (HP:0003546) | 1.81392283 |
| 82 | Foot dorsiflexor weakness (HP:0009027) | 1.79694077 |
| 83 | Abnormal atrioventricular conduction (HP:0005150) | 1.78840101 |
| 84 | Metatarsus adductus (HP:0001840) | 1.72040510 |
| 85 | Urinary urgency (HP:0000012) | 1.71000122 |
| 86 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.70886500 |
| 87 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.70886500 |
| 88 | Abnormality of the foot musculature (HP:0001436) | 1.70783513 |
| 89 | Type 2 muscle fiber atrophy (HP:0003554) | 1.67049322 |
| 90 | Abnormality of the Achilles tendon (HP:0005109) | 1.65401076 |
| 91 | Waddling gait (HP:0002515) | 1.63818242 |
| 92 | Right ventricular cardiomyopathy (HP:0011663) | 1.62585062 |
| 93 | Facial diplegia (HP:0001349) | 1.60470196 |
| 94 | Bundle branch block (HP:0011710) | 1.60184975 |
| 95 | Ankle clonus (HP:0011448) | 1.58907779 |
| 96 | Cholelithiasis (HP:0001081) | 1.58487065 |
| 97 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.57293818 |
| 98 | Prolonged QT interval (HP:0001657) | 1.56573329 |
| 99 | Stridor (HP:0010307) | 1.55084684 |
| 100 | Lipoatrophy (HP:0100578) | 1.54904673 |
| 101 | Abnormality of placental membranes (HP:0011409) | 1.54253189 |
| 102 | Amniotic constriction ring (HP:0009775) | 1.54253189 |
| 103 | Atrial fibrillation (HP:0005110) | 1.54010513 |
| 104 | Focal seizures (HP:0007359) | 1.53724821 |
| 105 | Ragged-red muscle fibers (HP:0003200) | 1.52813231 |
| 106 | Muscle fiber atrophy (HP:0100295) | 1.52620993 |
| 107 | Ventricular arrhythmia (HP:0004308) | 1.52348141 |
| 108 | Neurofibrillary tangles (HP:0002185) | 1.52250944 |
| 109 | Cerebral inclusion bodies (HP:0100314) | 1.51544236 |
| 110 | Dilated cardiomyopathy (HP:0001644) | 1.51299302 |
| 111 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.50922283 |
| 112 | Limited hip movement (HP:0008800) | 1.44755627 |
| 113 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.35606011 |
| 114 | Oligomenorrhea (HP:0000876) | 1.31432401 |
| 115 | Breech presentation (HP:0001623) | 1.28685992 |
| 116 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.28629440 |
| 117 | Increased intramyocellular lipid droplets (HP:0012240) | 1.28582620 |
| 118 | Adducted thumb (HP:0001181) | 1.28106124 |
| 119 | Short palpebral fissure (HP:0012745) | 1.22909504 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.66604849 |
| 2 | PHKG2 | 4.89402193 |
| 3 | PHKG1 | 4.89402193 |
| 4 | TTN | 4.74566791 |
| 5 | NME1 | 4.01912468 |
| 6 | PIK3CG | 2.37888515 |
| 7 | PINK1 | 2.28889224 |
| 8 | EPHA4 | 2.25572758 |
| 9 | NTRK3 | 2.18910364 |
| 10 | MAP3K7 | 2.11689942 |
| 11 | DMPK | 2.08765790 |
| 12 | LATS1 | 2.07049178 |
| 13 | PIK3CA | 1.69394704 |
| 14 | MUSK | 1.68456290 |
| 15 | MAP2K4 | 1.64976633 |
| 16 | STK39 | 1.64823992 |
| 17 | MAPK12 | 1.48824211 |
| 18 | PDK3 | 1.45377814 |
| 19 | PDK4 | 1.45377814 |
| 20 | ERBB3 | 1.41374884 |
| 21 | EPHB1 | 1.40520091 |
| 22 | MAPKAPK3 | 1.30620335 |
| 23 | PKN1 | 1.29579097 |
| 24 | EEF2K | 1.28575188 |
| 25 | NEK1 | 1.26480728 |
| 26 | PNCK | 1.21258328 |
| 27 | OXSR1 | 1.20680961 |
| 28 | MAP2K3 | 1.19892150 |
| 29 | MAP3K4 | 1.17356539 |
| 30 | PAK6 | 1.12443930 |
| 31 | CAMK2B | 1.11598203 |
| 32 | PDK2 | 1.09937690 |
| 33 | CAMK2G | 1.09786417 |
| 34 | CAMK2D | 1.05900896 |
| 35 | CASK | 1.02876143 |
| 36 | KSR2 | 1.01298365 |
| 37 | CCNB1 | 0.95607499 |
| 38 | CAMK2A | 0.94221331 |
| 39 | BCKDK | 0.88965076 |
| 40 | PRPF4B | 0.88885149 |
| 41 | MAP3K9 | 0.83385186 |
| 42 | ROCK2 | 0.77074607 |
| 43 | SGK1 | 0.74736774 |
| 44 | PTK2B | 0.73421241 |
| 45 | RIPK4 | 0.73418486 |
| 46 | DAPK2 | 0.73395579 |
| 47 | CDC7 | 0.71525443 |
| 48 | MAP2K6 | 0.70455983 |
| 49 | CDK19 | 0.70076983 |
| 50 | PLK2 | 0.68920898 |
| 51 | WNK1 | 0.68532913 |
| 52 | LATS2 | 0.68439116 |
| 53 | PRKAA2 | 0.68292655 |
| 54 | NTRK1 | 0.67056213 |
| 55 | MAPKAPK5 | 0.66223423 |
| 56 | CDK5 | 0.66051296 |
| 57 | MARK1 | 0.65959219 |
| 58 | NUAK1 | 0.64526701 |
| 59 | KSR1 | 0.62470909 |
| 60 | CAMK4 | 0.59792101 |
| 61 | IRAK2 | 0.59552075 |
| 62 | PAK3 | 0.58529799 |
| 63 | PRKD3 | 0.58192128 |
| 64 | TNIK | 0.56896849 |
| 65 | PRKAA1 | 0.55645532 |
| 66 | FGFR2 | 0.55072367 |
| 67 | PRKD1 | 0.54055934 |
| 68 | CAMK1 | 0.53875097 |
| 69 | PRKACB | 0.53101198 |
| 70 | TRPM7 | 0.52349292 |
| 71 | MARK2 | 0.51834407 |
| 72 | PRKG1 | 0.51163052 |
| 73 | PDPK1 | 0.49915246 |
| 74 | SGK223 | 0.49320889 |
| 75 | SGK494 | 0.49320889 |
| 76 | MINK1 | 0.48465822 |
| 77 | NTRK2 | 0.48429193 |
| 78 | ICK | 0.48250283 |
| 79 | UHMK1 | 0.48180436 |
| 80 | MAP3K2 | 0.47874663 |
| 81 | CAMK1G | 0.45697257 |
| 82 | BCR | 0.45413655 |
| 83 | MKNK2 | 0.44872637 |
| 84 | FGR | 0.44555170 |
| 85 | MAP2K7 | 0.44169627 |
| 86 | RPS6KA3 | 0.43859270 |
| 87 | TYRO3 | 0.43240775 |
| 88 | STK11 | 0.43049048 |
| 89 | RPS6KB2 | 0.42892463 |
| 90 | FER | 0.42550993 |
| 91 | NLK | 0.42285724 |
| 92 | BMPR1B | 0.42197111 |
| 93 | INSRR | 0.42022911 |
| 94 | DDR2 | 0.41813441 |
| 95 | SGK3 | 0.41777944 |
| 96 | PRKACA | 0.39676606 |
| 97 | PDK1 | 0.39501651 |
| 98 | TSSK6 | 0.39316159 |
| 99 | CAMK1D | 0.39157220 |
| 100 | PRKCG | 0.39094302 |
| 101 | VRK2 | 0.38888976 |
| 102 | FRK | 0.37432932 |
| 103 | BMPR2 | 0.37045212 |
| 104 | GRK5 | 0.36783504 |
| 105 | TIE1 | 0.36227461 |
| 106 | SGK2 | 0.36192143 |
| 107 | MAP2K1 | 0.36136160 |
| 108 | ROCK1 | 0.35907765 |
| 109 | ILK | 0.35851340 |
| 110 | TTK | 0.34878636 |
| 111 | NEK9 | 0.34717221 |
| 112 | MAPK10 | 0.34471049 |
| 113 | PRKCE | 0.34409375 |
| 114 | MOS | 0.33867408 |
| 115 | MAPK13 | 0.33373037 |
| 116 | AKT2 | 0.32779754 |
| 117 | WNK4 | 0.31618050 |
| 118 | MAPK7 | 0.31455202 |
| 119 | MAP3K6 | 0.31108578 |
| 120 | TAOK2 | 0.31099891 |
| 121 | CDK14 | 0.31074356 |
| 122 | DYRK1B | 0.29825107 |
| 123 | PLK4 | 0.28919951 |
| 124 | BRSK2 | 0.28432083 |
| 125 | TRIB3 | 0.28380036 |
| 126 | MAPK11 | 0.28360881 |
| 127 | MAP3K1 | 0.27614566 |
| 128 | RPS6KB1 | 0.27260537 |
| 129 | LIMK1 | 0.27077388 |
| 130 | RIPK1 | 0.25866225 |
| 131 | STK3 | 0.23941797 |
| 132 | MAPK4 | 0.23381122 |
| 133 | EIF2AK3 | 0.22056488 |
| 134 | STK38L | 0.21449847 |
| 135 | MAP3K13 | 0.21205910 |
| 136 | MAP3K10 | 0.20825236 |
| 137 | BRAF | 0.20465202 |
| 138 | PRKDC | 0.19350866 |
| 139 | PLK1 | 0.18066795 |
| 140 | IRAK1 | 0.15981543 |
| 141 | RPS6KA1 | 0.15947369 |
| 142 | CSNK1E | 0.14676714 |
| 143 | EIF2AK2 | 0.13791423 |
| 144 | TRIM28 | 0.11898086 |
| 145 | MKNK1 | 0.11889165 |
| 146 | PLK3 | 0.11161579 |
| 147 | PBK | 0.10802801 |
| 148 | BUB1 | 0.10663725 |
| 149 | * GSK3B | 0.10086641 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.16144598 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.06009283 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.88183858 |
| 4 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.81711939 |
| 5 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.40441586 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.23766618 |
| 7 | Calcium signaling pathway_Homo sapiens_hsa04020 | 2.20028755 |
| 8 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.19575537 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.10972609 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.09737206 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.06697288 |
| 12 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.88468309 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.85804823 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.83195726 |
| 15 | GABAergic synapse_Homo sapiens_hsa04727 | 1.74897322 |
| 16 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.66727059 |
| 17 | Long-term depression_Homo sapiens_hsa04730 | 1.63351650 |
| 18 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.63216845 |
| 19 | Salivary secretion_Homo sapiens_hsa04970 | 1.62912226 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.58324342 |
| 21 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.55425843 |
| 22 | Alzheimers disease_Homo sapiens_hsa05010 | 1.51859269 |
| 23 | Morphine addiction_Homo sapiens_hsa05032 | 1.50894825 |
| 24 | Circadian rhythm_Homo sapiens_hsa04710 | 1.48714416 |
| 25 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.47133696 |
| 26 | Insulin secretion_Homo sapiens_hsa04911 | 1.42195363 |
| 27 | Olfactory transduction_Homo sapiens_hsa04740 | 1.41994168 |
| 28 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.41065305 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.40411356 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.39060452 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.37712370 |
| 32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.36885370 |
| 33 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.35154242 |
| 34 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.30596370 |
| 35 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.29250579 |
| 36 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.27327456 |
| 37 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.27056271 |
| 38 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.25439261 |
| 39 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.24966826 |
| 40 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.21659267 |
| 41 | Parkinsons disease_Homo sapiens_hsa05012 | 1.21264125 |
| 42 | Tight junction_Homo sapiens_hsa04530 | 1.18565143 |
| 43 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.18290075 |
| 44 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.18207415 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.12453730 |
| 46 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.11183218 |
| 47 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.10100451 |
| 48 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.04145506 |
| 49 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.03837071 |
| 50 | Taste transduction_Homo sapiens_hsa04742 | 1.01298580 |
| 51 | Axon guidance_Homo sapiens_hsa04360 | 0.96466504 |
| 52 | Gap junction_Homo sapiens_hsa04540 | 0.95019658 |
| 53 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.94378586 |
| 54 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.90793703 |
| 55 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.89574449 |
| 56 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.88236846 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.87031068 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86893478 |
| 59 | Insulin resistance_Homo sapiens_hsa04931 | 0.86625181 |
| 60 | Melanogenesis_Homo sapiens_hsa04916 | 0.86107007 |
| 61 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.85978443 |
| 62 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.83136162 |
| 63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81495764 |
| 64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81355424 |
| 65 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.78463267 |
| 66 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.77989088 |
| 67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.77476983 |
| 68 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.77261608 |
| 69 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.76688507 |
| 70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73222309 |
| 71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.72847244 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.72659061 |
| 73 | Cocaine addiction_Homo sapiens_hsa05030 | 0.71393384 |
| 74 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.71186645 |
| 75 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.68031051 |
| 76 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.67650317 |
| 77 | Carbon metabolism_Homo sapiens_hsa01200 | 0.66844073 |
| 78 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.65947873 |
| 79 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.65108111 |
| 80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.63884540 |
| 81 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62941725 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62792488 |
| 83 | Focal adhesion_Homo sapiens_hsa04510 | 0.62500459 |
| 84 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.60451538 |
| 85 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.60073386 |
| 86 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59938955 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59062628 |
| 88 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.58543091 |
| 89 | Huntingtons disease_Homo sapiens_hsa05016 | 0.58476310 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58136834 |
| 91 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.58095725 |
| 92 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56162499 |
| 93 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55390418 |
| 94 | Purine metabolism_Homo sapiens_hsa00230 | 0.54908925 |
| 95 | Glioma_Homo sapiens_hsa05214 | 0.52012285 |
| 96 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.51508422 |
| 97 | RNA degradation_Homo sapiens_hsa03018 | 0.50462416 |
| 98 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.49904052 |
| 99 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.49699636 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49565766 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48534255 |
| 102 | Viral myocarditis_Homo sapiens_hsa05416 | 0.48072133 |
| 103 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48049263 |
| 104 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47922490 |
| 105 | Mismatch repair_Homo sapiens_hsa03430 | 0.45436401 |
| 106 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44465382 |
| 107 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.44062939 |
| 108 | Adherens junction_Homo sapiens_hsa04520 | 0.43702759 |
| 109 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43380724 |
| 110 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.43267782 |
| 111 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.42341988 |
| 112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42236672 |
| 113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39292694 |
| 114 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39005638 |
| 115 | Thyroid cancer_Homo sapiens_hsa05216 | 0.38531256 |
| 116 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.37571973 |
| 117 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37332910 |
| 118 | Peroxisome_Homo sapiens_hsa04146 | 0.37297185 |
| 119 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.37130514 |
| 120 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.36900092 |
| 121 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.35647027 |
| 122 | Histidine metabolism_Homo sapiens_hsa00340 | 0.34029670 |
| 123 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33559817 |
| 124 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32583587 |
| 125 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.31323589 |
| 126 | RNA transport_Homo sapiens_hsa03013 | 0.30907129 |
| 127 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.30790477 |
| 128 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.30252083 |
| 129 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.30055006 |
| 130 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.29510322 |
| 131 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.29224276 |
| 132 | Basal transcription factors_Homo sapiens_hsa03022 | 0.29159222 |
| 133 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25122555 |
| 134 | Phototransduction_Homo sapiens_hsa04744 | 0.22843236 |
| 135 | DNA replication_Homo sapiens_hsa03030 | 0.21035946 |
| 136 | Proteasome_Homo sapiens_hsa03050 | 0.19660651 |
| 137 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.18267322 |

